Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Open | $130.130 |
Close | - |
Volume / Avg. | 4.729M / 8.408M |
Day Range | 130.130 - 131.910 |
52 Wk Range | 99.140 - 133.100 |
Market Cap | $332.941B |
P/E Ratio | 145.244 |
Dividend Yield | 2.360% |
Exchange | NYSE |
RSI | 69 |
Short Interest | 0.77% |
Days to Cover | 2.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Truist Securities on Friday, April 26, 2024. The analyst firm set a price target for 143.00 expecting MRK to rise to within 12 months (a possible 8.79% upside). 41 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $131.44 last updated Today at April 26, 2024 at 3:07 PM EDT.
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2024 to stockholders of record on March 14, 2024.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.